• Suitable for overmolding onto PC and TPU • Contains bio-renewable content • Vibration damping performance and UV resistance comparable to traditional TPEs KEY REQUIREMENTS https://www.avient.com/products/thermoplastic-elastomers/resound-om-thermoplastic-elastomers

All Rights Reserved. https://www.avient.com/products/thermoplastic-elastomers/versaflex-thermoplastic-elastomers

All Rights Reserved. https://www.avient.com/sites/default/files/2023-11/Cesa Fiber Additives Hydrophobic for PP Nonwovens Product Bulletin.pdf Slide 1: Medical textile manufacturer

All Rights Reserved https://www.avient.com/products/polymer-additives/fiber-additives/cesa-fiber-additives Slide 1: Fabric MASK manufacturer

Cibodas 15138 Kecamatan Cibodas, Tangerang Indonesia Scope Category I Production of customer specific Masterbatches for Food packaging materials on the dedicated extrusion lines Normative base ISO 22000:2018 Food Safety Management Systems - Requirements for any organization in the food chain Reg. no. 46391 Page 1 of 1 Validity 25. 02. 2024 – 24. 02. 2027 Issue 25. 02. 2024 A.Grisard, President SQS F.

All Rights Reserved. https://www.avient.com/products/vivo-formulations-healthcare/neusoft-thermoplastic-polyurethanes Slide 1: Medical device Manufacturer

AVIENT SOLUTION BIOCOMPATIBILITY + SOFT TOUCH LEARN MORE © 2020, All Right Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 https://www.polyone.com/products/thermoplastic-elastomers/dynaflex-thermoplastic-elastomers European medical device manufacturer

All Rights Reserved. https://www.avient.com/products/vinyl-formulations/vinyl-plastisols-organosols/core-non-phthalate-plastisols

In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; estimated capital expenditures; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings and environmental liabilities; and financial results. Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows, including without any limitation, any supply chain and logistics issues; • Our ability to achieve the strategic and other objectives relating to the acquisition of Clariant’s Color business, including any expected synergies; • Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • An inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Our ability to consummate and successfully integrate acquisitions; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and • Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2020 under Item 1A, “Risk Factors.” 25 We are a specialty formulator that enables many of the world’s products through innovation and custom solutions.

We expect momentum from our high profit portfolios in defense and healthcare markets, along with disciplined cost controls and productivity initiatives, to contribute to continued margin expansion over the prior year.” We still expect minimal direct impact from tariffs as we primarily source raw materials and manufacture our products locally in the regions that we serve. By intersecting our broad portfolio of technologies with the product roadmaps of our customers, we help create differentiated and high-performance products that make the world better and more sustainable.